TMCnet News
SAFE-BioPharma Association Certifies HID Global's IdenTrust Digital Certificates as Compliant with Its Digital Identity and Signature StandardsHID Global®, a worldwide leader in trusted identity solutions, today announced that its IdenTrust® Enterprise Solution has been certified compliant with SAFE-BioPharma Association's digital identity and signature standards, paving the way for the association's global member companies to confidently deploy the solution. SAFE-BioPharma Association was created by the biopharmaceutical industry and its regulators, and the standards developed are now used to provide global high-assurance identity trust for cyber-transactions throughout the pharmaceutical and healthcare community. Pharmaceutical and healthcare companies can use HID IdenTrust digital certificates to provide digital credentials that improve the user experience, enhance patient safety and allow for secure access to websites, networks, systems or applications with strong, two-factor authentication, which is critical for regulatory compliance and countering cyberattacks. The digital certificates also support advanced security use cases, including data encryption and digital signing capabilities. "We are pleased to have certified our IdenTrust Digital Certificates with SAFE-BioPharma standards," said Brad Jarvis, Vice President and Managing Director, Identity & Access Management, with HID Global. "With our IdenTrust digital certificates along with our portfolio of HID identity and access management products, we look forward to helping SAFE-BioPharma members and the wider pharmaceutical and healthcare communities to solve challenges they face related to regulatory compliance, end-user authentication, digital signing, interoperability and data protection." HID Global's IdenTrust digital certificates can be used by pharmaceutical companies and healthcare organizations to secure applications with two-factor authentication thereby increasing overall information security when compared to more traditional, password-only protection. HID Global's IdenTrust digital certificates enable digital signing of clinical trial information to regulatory bodies, such as the United States Federal & Drug Administration (FDA). Additionally, SAFE-BioPharma compliant IdenTrust digital certificatescan be used to digitally sign electronic documents to create a legally binding digital signature. This method of creating digital signature(s) is integral to processes and practices in the pharmaceutical and healthcare industry, such as digitally signing ePrescriptions for controlled substances in compliance with Drug Enforcement Agency's (DEA) rules for creating Electronic Prescriptions of Controlled Substances (EPCS). Of course the same IdenTrust digital certificates can also be used for more traditional uses such as to secure emails, strong user authentication, smartcard logon, and data protection both in transit and at rest. "Knowing who is accessing systems or signing documents is critical in the healthcare industry where the impact of a mistake or malicious action can have serious implications for patient safety or create serious risks to healthcare companies who must protect personal health information," said Matt King, Director, SAFE-BioPharma Association. "SAFE-BioPharma is pleased that HID Global's IdenTrust solution is now available to our member companies who can benefit from HID Global's experience and industry leadership." Stay Connected with HID Global Visit our Media Center, read our Industry Blog, and follow us on Facebook, LinkedIn and Twitter. About SAFE-BioPharma Association, LLC As part of the Health Information Sharing and Analysis Center (H-ISAC), SAFE-BioPharma Association, LLC provides global, high-assurance identity trust for cyber-transactions in the biopharmaceutical and healthcare industries. The SAFE-BioPharma® digital identity and signature standards were crafted to mitigate risk associated with electronic transactions by protecting intellectual property and patient data using secure, enforceable, and regulatory compliant mechanisms. SAFE-BioPharma® is a trademark of SAFE-BioPharma Association. Use of this trademark requires approval from SAFE-BioPharma Association. NH-ISAC is a non-profit, member-driven organization offering healthcare stakeholders a trusted community and forum for sharing cyber and physical threat indicators, vulnerabilities, best practices and mitigation strategies. About HID Global HID Global powers the trusted identities of the world's people, places and things. We make it possible for people to transact safely, work productively and travel freely. Our trusted identity solutions give people convenient access to physical and digital places and connect things that can be identified, verified and tracked digitally. Millions of people around the world use HID products and services to navigate their everyday lives, and over 2 billion things are connected through HID technology. We work with governments, educational institutions, hospitals, financial institutions, industrial businesses and some of the most innovative companies on the planet. Headquartered in Austin, Texas, HID Global has over 3,000 employees worldwide and operates international offices that support more than 100 countries. HID Global® is an ASSA ABLOY Group brand. For more information, visit www.hidglobal.com. © 2019. HID Global Corporation/ASSA ABLOY AB. All rights reserved. HID, HID Global, the HID Blue Brick logo the Chain Design and IdenTrust are trademarks or registered trademarks of HID Global, ASSA ABLOY AB, or its affiliates(s) in the US and other countries and may not be used without permission. All other trademarks, service marks, and product or service names are trademarks or registered trademarks of their respective owners. View source version on businesswire.com: https://www.businesswire.com/news/home/20190220005921/en/ |
